Option Care Health, Inc.·4

May 7, 5:04 PM ET

SULLIVAN TIMOTHY P 4

4 · Option Care Health, Inc. · Filed May 7, 2026

Research Summary

AI-generated summary of this filing

Updated

Option Care Health (OPCH) Director Timothy P. Sullivan Buys 24,154 Shares

What Happened
Timothy P. Sullivan, a director of Option Care Health, bought 24,154 shares of OPCH common stock in an open-market/private purchase (transaction code P) on May 7, 2026. The weighted average purchase price was $20.69 per share, for a total reported cost of $499,671. This is a direct purchase (a buy), which some investors view as a positive signal but does not guarantee future performance.

Key Details

  • Transaction date: May 7, 2026 (filed May 7, 2026); transaction code: P (purchase).
  • Shares purchased: 24,154; weighted average price: $20.69; total value: $499,671.
  • Price range: purchases occurred at prices between $20.47 and $20.69 per share (see footnote).
  • Shares owned after transaction: not disclosed in the filing.
  • Footnote: Reporting person states the $20.69 figure is a weighted average of multiple trades and will provide a breakdown of shares purchased at each price upon request by the SEC, issuer, or a security holder.
  • No indication in the filing that this was a late report.

Context
This was a straightforward equity purchase by a company director. For retail investors, director purchases can be of interest because they represent insiders adding to holdings, but they should be considered alongside other information about the company's fundamentals and insider ownership trends.

Insider Transaction Report

Form 4
Period: 2026-05-07
Transactions
  • Purchase

    Common Stock

    [F1]
    2026-05-07$20.69/sh+24,154$499,67173,383 total
Footnotes (1)
  • [F1]Reflects the weighted average price of 24,154 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on May 7, 2026 with purchase prices ranging from $20.47 to $20.69 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Signature
/s/ Michael Bavaro, attorney-in-fact for Mr. Sullivan|2026-05-07

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4